• Collaboration to advance Global Drug Discovery Infrastructure
    Matthew Segall

News & Views

Collaboration to advance Global Drug Discovery Infrastructure

Nov 26 2020

Drug discovery software developer Optibrium has announced a collaboration with US-based MSD which has adopted the Cambridge, UK company's StarDrop™ software as a central component of their cheminformatics infrastructure. The partnership will also include the joint development of new tools, to improve cycle times, efficiency and productivity of the drug discovery process.

Dr Matthew Segall, Optibrium’s CEO, commented, “We are delighted to enter this collaboration to contribute to MSD’s world-leading cheminformatics infrastructure. We look forward to working together to advance new tools based around StarDrop to further refine our compound design platform.”

MSD is a tradename of Merck & Co Inc, Kenilworth NJ

Further information www.online


Digital Edition

LMUK 49.7 Nov 2024

November 2024

News - Research & Events News   - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...

View all digital editions

Events

MEDICA 2024

Nov 11 2024 Dusseldorf, Germany

FILTECH

Nov 12 2024 Cologne, Germany

Intech

Nov 12 2024 Tel Aviv, Israel

analytica China

Nov 18 2024 Shanghai, China

Pharma Asia

Nov 20 2024 Karachi, Pakistan

View all events